<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505775</url>
  </required_header>
  <id_info>
    <org_study_id>23NaMRT-AI</org_study_id>
    <nct_id>NCT03505775</nct_id>
  </id_info>
  <brief_title>Evaluation of the Muscular and Cutaneous Sodium Storage by 23Na MRI in Patients With Chronic Adrenal Insufficiency</brief_title>
  <official_title>Evaluation of the Muscular and Cutaneous Sodium Storage by 23Na Magnetic Resonance Imaging in Patients With Chronic Adrenal Insufficiency Compared to Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuerzburg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuerzburg University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the sodium content in the calf muscle and the skin obtained via
      23Na-magnetic resonance imaging in patients with chronic adrenal insufficiency compared to
      healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with chronic adrenal insufficiency depend on lifelong glucocorticoid and
      mineralocorticoid replacement therapy. Monitoring is based on clinical and laboratory
      parameters reflecting hemodynamic stability, electrolyte status and plasma renin
      concentration. Reduced subjective well-being is however often described by these patients in
      absence of clinical or laboratory abnormalities and is thus a strong indicator of the gap
      between the concept of adequate hormone substitution and patients' requirements. This study
      investigates the sodium content in the calf muscle and the skin obtained via 23Na-magnetic
      resonance imaging (MRI) in patients with chronic adrenal insufficiency compared to age-, sex-
      and BMI- matched healthy controls. The aim of the study is to evaluate the potential role of
      23Na-MRI for monitoring of hormone replacement by investigating tissue sodium concentrations
      in patients with adrenal insufficiency.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 14, 2017</start_date>
  <completion_date type="Actual">October 31, 2017</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle sodium content</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of the sodium content of the calf muscle. Relative sodium signal intensities were calculated as ratio of tissue sodium intensity and the intensity of a vial containing a concentration of 100mmol/l.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin sodium content</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of the sodium content of the calf skin. Relative sodium signal intensities were calculated as ratio of tissue sodium intensity and the intensity of a vial containing a concentration of 100mmol/l.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Adrenal Insufficiency</condition>
  <arm_group>
    <arm_group_label>23Na-MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A 23Na magnetic resonance imaging of the calf (muscle and skin) was performed in every participating patient after clinical and laboratory examinations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>23Na magnetic resonance imaging</intervention_name>
    <description>Imaging/diagnostic: Evaluation of the muscular and cutaneous sodium storage by 23Na magnetic resonance imaging. 23Na magnetic resonance imaging: 23NA-MRI protocol on a 3T scanner (Magnetom PRISMA, Siemens, Erlangen) implementing a 3D sequence.</description>
    <arm_group_label>23Na-MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Written informed consent

          -  Chronic adrenal insufficiency (first diagnosis &gt; 6months), stable hormone replacement
             therapy with glucocorticoids (no dose-adjustment &gt;50mg hydrocortisone within the last
             8 weeks) and mineralocorticoids (only primary adrenal insufficiency)! Or healthy
             control (no adrenal insufficiency, normal serum-electrolytes, normotensive blood
             pressure, no medication with a known influence on the electrolyte balance)!

        Exclusion Criteria:

          -  Pregnancy or breast-feeding

          -  Metal-implant (not MRI-compatible)

          -  Claustrophobia

          -  Chronic internistic disease (hypertension, heart failure, liver cirrhosis)

          -  Polydipsia (&gt;4l/d)

          -  Long-term medication that can cause a hyponatraemia (for example diuretics)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefanie Hahner, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Wuerzburg, Dept. of medicine I, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Wuerzburg, Dept. of medicine I</name>
      <address>
        <city>Wuerzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hahner S, Loeffler M, Fassnacht M, Weismann D, Koschker AC, Quinkler M, Decker O, Arlt W, Allolio B. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab. 2007 Oct;92(10):3912-22. Epub 2007 Aug 7.</citation>
    <PMID>17684047</PMID>
  </reference>
  <reference>
    <citation>Quinkler M, Oelkers W, Remde H, Allolio B. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2015 Jan;29(1):17-24. doi: 10.1016/j.beem.2014.08.008. Epub 2014 Aug 27. Review.</citation>
    <PMID>25617169</PMID>
  </reference>
  <reference>
    <citation>Kopp C, Linz P, Dahlmann A, Hammon M, Jantsch J, Müller DN, Schmieder RE, Cavallaro A, Eckardt KU, Uder M, Luft FC, Titze J. 23Na magnetic resonance imaging-determined tissue sodium in healthy subjects and hypertensive patients. Hypertension. 2013 Mar;61(3):635-40. doi: 10.1161/HYPERTENSIONAHA.111.00566. Epub 2013 Jan 21.</citation>
    <PMID>23339169</PMID>
  </reference>
  <reference>
    <citation>Kopp C, Linz P, Wachsmuth L, Dahlmann A, Horbach T, Schöfl C, Renz W, Santoro D, Niendorf T, Müller DN, Neininger M, Cavallaro A, Eckardt KU, Schmieder RE, Luft FC, Uder M, Titze J. (23)Na magnetic resonance imaging of tissue sodium. Hypertension. 2012 Jan;59(1):167-72. doi: 10.1161/HYPERTENSIONAHA.111.183517. Epub 2011 Dec 5.</citation>
    <PMID>22146510</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <last_update_submitted>April 12, 2018</last_update_submitted>
  <last_update_submitted_qc>April 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hormone replacement</keyword>
  <keyword>Mineralocorticoids</keyword>
  <keyword>23Na-magnetic resonance imaging</keyword>
  <keyword>Tissue sodium content</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adrenal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

